文献
J-GLOBAL ID:201802213985178510
整理番号:18A1712181
進行肝細胞癌治療のためのTACEとソラフェニブの最善の併用はどの程度か?系統的レビューとネットワークメタ分析【JST・京大機械翻訳】
Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
著者 (9件):
Feng Fan
(School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, P.R. China)
,
Jiang Qiyu
(Research Center for Clinical and Translational Medicine, 302 Military Hospital of China, Beijing 100039, P.R. China)
,
Jia Hui
(The Comprehensive Liver Cancer Center, 302 Military Hospital of China, Beijing 100039, P.R. China)
,
Sun Huiwei
(Research Center for Clinical and Translational Medicine, 302 Military Hospital of China, Beijing 100039, P.R. China)
,
Chai Yantao
(Research Center for Clinical and Translational Medicine, 302 Military Hospital of China, Beijing 100039, P.R. China)
,
Li Xiaojuan
(Research Center for Clinical and Translational Medicine, 302 Military Hospital of China, Beijing 100039, P.R. China)
,
Rong Guanghua
(The Comprehensive Liver Cancer Center, 302 Military Hospital of China, Beijing 100039, P.R. China)
,
Zhang Yingshi
(Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, P.R. China)
,
Li Zhengping
(School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, P.R. China)
資料名:
Pharmacological Research
(Pharmacological Research)
巻:
135
ページ:
89-101
発行年:
2018年
JST資料番号:
E0326B
ISSN:
1043-6618
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)